From Hell To Veins

November 29, 2009

H1N1, H2N2, H3N2, and H5N1 Combo DNA Influenza Vaccine Ready

My Commentary:
As I have LONG told the reader the so-called pandemics (which I told the reader were coming BEFORE the Mexican outbreak) would usher in the words “DNA vaccines” into the everyday vocabulary of Joe Six Pack. However, the reference and usage to DNA vaccines in this article is NOT in the ‘same’ context as the way they will be used at a future date, as I have also laid out. What is import for the reader, is to take note of the claim made in the article by the manufacture that ferrets got 100% protection against ALL strains. While I will always be skeptical of such claims, in my earliest posting (before the Mexican outbreak) on Barbara Loe Fisher’s blog Vaccine Awakenings (under the handle John H) I explained that these pandemics that had not happened yet would come in waves and, by ‘miracle’, DNA vaccines would be SEEMINGLY the next polio type of triumph. At this point I want to let the reader know this blog’s purpose is NOT to focus on and track the pandemic strains of these viruses. The purpose of this blog is to track POLICY surrounding these so-called pandemics, warning the reader they will be used to mandate a world wide MANDATORY vaccine policy that WILL BE USED FOR POPULATION CONTROL PURPOSES, as was stated at the Club Of Rome symposium on population reduction I attended IN 1988.

A look through the key hole for you on population reduction research under the guise of “wearing the white hat”.

Inovio Biomedical announces positive test results of its consensus influenza vaccines
20. November 2009 06:39

Inovio Biomedical Corporation (NYSE Amex:INO), a leader in DNA vaccine design, development and delivery, announced today that a combination of its synthetic consensus H1N1, H2N2, H3N2, and H5N1 influenza vaccine candidates achieved protective antibody responses against several different influenza sub-types and strains in ferrets. In addition, ferrets immunized with Inovio’s SynConTM universal flu vaccine combinations were 100% protected against death and sickness in a challenge with the A/H1N1 (2009) swine-origin influenza. Dr. Niranjan Y. Sardesai, Inovio’s SVP, Research and Development, presented this data at the Influenza Congress USA 2009 in Washington, DC, in a presentation titled, “Development of Universal SynCon™ DNA Vaccines for Pandemic and Seasonal Influenza.”

Read rest of article below.
New DNA Based Vaccines Ready For (MANDATORY?) Market.

Advertisements

Create a free website or blog at WordPress.com.